Lixisenatide is a glucagon-like peptide-1 (GLP-1) receptor agonist that can be used in the treatment of type 2 diabetes mellitus (T2DM).It is an injectable diabetes medicine that helps control blood sugar levels.

320367-13-3

C215H347N61O65S

4858.49

H2O:106 mg/mL (21.82 mM),Need ultrasonic and warming
Powder: -20°C for 3 years
In solvent: -80°C for 2 years